Gilead Sciences Profile Banner
Gilead Sciences Profile
Gilead Sciences

@GileadSciences

73,759
Followers
205
Following
2,010
Media
4,317
Statuses

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. Read more:

Foster City, California
Joined June 2011
Don't wanna be here? Send us removal request.
@GileadSciences
Gilead Sciences
3 years
Thanks to scientific advances in treatment, people with #HIV are living longer. Martin Rhee, Executive Director of Clinical Research, discusses what this means for the next wave of Gilead’s scientific innovation in HIV. #CROI2021
0
37
778
@GileadSciences
Gilead Sciences
3 years
Driving innovation in #HIV is about more than scientific research. Gilead’s Douglas Brooks shares his thoughts on how powerful partnerships can make a huge difference in the global effort to end the epidemic: #CROI2021
0
56
860
@GileadSciences
Gilead Sciences
2 years
Spain’s Ferran Pujol has spent decades supporting and advocating for the #HIV community. After being diagnosed in the 1980s, Ferran became #FearlessForAll by starting @BCNCheckpoint , which provides testing, counseling and a safe place for men living with HIV. #WorldAIDSDay
0
247
5K
@GileadSciences
Gilead Sciences
2 years
At Gilead, 2021 was the year we moved ‘Forward and Onward Together.’ Through the promotion of inclusion and diversity, transformative science and renewed commitments to sustainability, we worked toward furthering our mission of making the world a healthier place for everyone.
0
420
4K
@GileadSciences
Gilead Sciences
2 years
Kenya-born advocate Angelina Namiba has been living with #HIV for 28 years and now serves as a mentor for women and moms in her community. Her work with @4Mproject , a UK-based network of immigrant and other women living with HIV, makes her #FearlessForAll . #WorldAIDSDay
0
299
4K
@GileadSciences
Gilead Sciences
2 years
Since coming out to her family as transgender in 1997, Rena Janamnuaysook has been #FearlessForAll for her community. Among her work: co-founding a first-of-its-kind clinic in Thailand that provides healthcare and #HIV -related services for the transgender community. #WorldAIDSDay
0
283
4K
@GileadSciences
Gilead Sciences
2 years
Gina Brown has lived with #HIV for 27 years and calls herself “a social worker by training but an activist by birth.” Through the @SouthernAIDSCo , she works to dismantle stigma and help build better futures for women and all living with HIV. #FearlessForAll #WorldAIDSDay
0
226
4K
@GileadSciences
Gilead Sciences
3 years
Progress in #HIV treatment has been transformative, but the fact is nearly 40 million people are still living with HIV worldwide. Gilead’s Jared Baeten shares how continued and unrelenting scientific innovation is critical to ending the epidemic. #CROI2021
0
68
885
@GileadSciences
Gilead Sciences
2 years
As a teenager, Idan Barak had his first healthy conversation about sex at the Israel AIDS Task Force. Years later, as Executive Director of the organization, he works to reduce stigma and provides counseling and support for people living with #HIV . #FearlessForAll #WorldAIDSDay
0
157
4K
@GileadSciences
Gilead Sciences
2 years
Meet the doctors, activists and advocates from Sustained Health Initiatives of the Philippines who are working to provide access and healthcare resources to those living with #HIV . See their full story: #TogetherAgainstHIV
0
363
3K
@GileadSciences
Gilead Sciences
3 years
Gilead's Devi SenGupta knows the importance of innovating new #HIV techniques to advance cure research. See what this research means to Devi and how this data at #CROI2021 will impact the entire scientific community.
0
44
748
@GileadSciences
Gilead Sciences
2 years
Senegal has had widespread #HIV prevention and treatment success over the past decade. When Fann Hospital faced its own barrier to patient care, see how one doctor — supported by Gilead — rebuilt the foundations of hope for his patients.
0
678
2K
@GileadSciences
Gilead Sciences
2 years
We’re excited to mark #WorldAIDSDay alongside @UNAIDS and to launch a campaign celebrating a group of resilient, determined and courageous individuals who are working to help #EndAIDSby2030 . This week, we’ll be sharing their incredible stories of being #FearlessForAll .
Tweet media one
0
117
2K
@GileadSciences
Gilead Sciences
2 years
Ending the #HIV epidemic and ending inequalities requires resilience, determination and courage. This #WorldAIDSDay , we honor the brave, bold individuals who are #FearlessForAll and have been working for years to help #EndAIDSby2030 .
0
223
2K
@GileadSciences
Gilead Sciences
3 years
This Women and Girls HIV/AIDS Awareness Day, we honor those helping to forge gender equity around the world. Meet Yvette Raphael, who is advancing prevention research in South Africa, where women and girls are disproportionately impacted by #HIV . #NWGHAAD
Tweet media one
0
35
539
@GileadSciences
Gilead Sciences
2 years
People around the world have worked tirelessly over the last 21 months to treat #COVID19 patients and develop medicines to help them. As we head toward Thanksgiving, we’re expressing thanks for the researchers, scientists and frontline healthcare workers who have helped so many.
Tweet media one
0
163
2K
@GileadSciences
Gilead Sciences
7 years
Fight stigma, wear red, share your story or selfie. #WorldAIDSDay
Tweet media one
29
1K
1K
@GileadSciences
Gilead Sciences
10 months
In celebration of the @BeOurCOMPASS fifth anniversary, we are amplifying the stories of five grantees and recognizing how they are agents of progress in helping to end the HIV epidemic in the Southern U.S. In our second video, meet Transinclusive Group from South Florida.
0
204
1K
@GileadSciences
Gilead Sciences
6 years
What does #WorldAIDSDay mean to you? Add your photo to the #WorldAIDSDay #redribbon mosaic and show support for those living with, or impacted by, HIV:
60
599
1K
@GileadSciences
Gilead Sciences
3 years
Morris Singletary, founder of PoZitive2PoSitive, grew up in the Southern United States and believes that collaboration with the Black church is essential in addressing the #HIVEpidemic . Here’s why: #GileadCompass
0
147
891
@GileadSciences
Gilead Sciences
9 months
In celebration of the @BeOurCOMPASS fifth anniversary, we are amplifying the stories of five grantees, recognizing their contributions to help end the HIV epidemic in the Southern U.S.
0
116
763
@GileadSciences
Gilead Sciences
6 years
What does #WorldAIDSDay mean to you? Add your photo to the #WorldAIDSDay #redribbon mosaic and stand united with those living with, or impacted by, #HIV : .
46
331
735
@GileadSciences
Gilead Sciences
3 years
Our impact is greatest when our science is more inclusive. During #2021BHPS , Gilead researcher Moupali Das talked about the importance of ensuring community leaders have a seat at the table when it comes to #HIV research.
0
42
600
@GileadSciences
Gilead Sciences
3 years
In Zambia, through remarkable determination and resilience in the face of sexual violence, #DREAMS Ambassador Grace Njobvu has become an empowered and #AIDS -free source of hope. Gilead is proud to support her efforts through @PEPFAR ’s DREAMS Partnership: .
31
106
712
@GileadSciences
Gilead Sciences
3 years
Our COMPASS Initiative is focused on helping communities most affected by #HIV . Now, we’re bringing a faith-based component to the work with the aim of reaching more people living with or at risk of HIV: #GileadCOMPASS
0
109
709
@GileadSciences
Gilead Sciences
2 years
“Telemedicine provides us with a variety of options and a variety of providers, but there’s nothing like that in-person connection,” says Gilead's Dr. Shanell McGoy. Read more about @glaad 's research on COVID-19's impact on HIV care and prevention.
0
147
652
@GileadSciences
Gilead Sciences
6 years
Thank you all for joining our #WorldAIDSDayChat with @AIDS_United , we hope you learned a lot from the participants. In recognition of #WorldAIDSDay , we invite you to upload a picture onto our mosaic dedicated to HIV/AIDS awareness: .
Tweet media one
10
224
657
@GileadSciences
Gilead Sciences
4 years
Gilead announces results from Phase 3 trial of investigational antiviral in patients with severe COVID-19: .
Tweet media one
53
324
561
@GileadSciences
Gilead Sciences
4 years
We have accelerated and expanded production of our investigational COVID-19 treatment and continue to increase supply. Hear from our Chairman & CEO on our manufacturing progress and intent to donate supply following potential regulatory authorizations: .
Tweet media one
50
215
557
@GileadSciences
Gilead Sciences
4 years
We announced the price today for our investigational antiviral for the treatment of COVID-19. We believe our unique approach will provide broad and equitable access. Read more from our Chairman & CEO: .
Tweet media one
3K
267
505
@GileadSciences
Gilead Sciences
3 years
Curing #HIV remains a formidable challenge, but our leaders believe it's a goal worth reaching for. For Senior Research Scientist Jeff Murry, answers may lie in lessons learned from scientific fields outside of HIV.
0
47
485
@GileadSciences
Gilead Sciences
4 years
Gilead’s investigational antiviral for the treatment of COVID-19 receives @US_FDA Emergency Use Authorization. This more readily enables treatment of hospitalized patients with severe COVID-19 disease in the United States. Read more: .
Tweet media one
52
271
496
@GileadSciences
Gilead Sciences
4 years
Gilead has been working at unprecedented speed to enroll patients in clinical trials of our investigational treatment for COVID-19. Multiple studies are ongoing & we are on track to have initial data in the coming weeks. Read more from our Chairman & CEO: .
Tweet media one
68
199
489
@GileadSciences
Gilead Sciences
4 years
Gilead has submitted a request to the FDA to rescind the orphan drug designation it was granted for its investigational antiviral for the treatment of COVID-19 and is waiving all benefits that accompany the designation. Read more: .
60
177
449
@GileadSciences
Gilead Sciences
2 years
To honor the Quilt's 35th anniversary, supporters gathered in Jackson, Miss., to “Change The Pattern,” reimagining the HIV epidemic response in the U.S. South. Each panel commemorates a person who died from AIDS-related causes and the value of community, remembrance and hope.
Tweet media one
0
90
425
@GileadSciences
Gilead Sciences
3 years
We’re heading to the @HIVR4Px Virtual Conference today with new insights in #HIVResearch . We’ll be joining experts to discuss the latest challenges and solutions in the evolving field of #HIVPrevention .
Tweet media one
0
40
422
@GileadSciences
Gilead Sciences
3 years
Shanell McGoy, Director of Public Affairs, is part of a team that helped develop a racial equity and social justice corporate giving strategy at Gilead. Here, she discusses this work and how George Floyd’s killing impacted her as a professional and a new mom.
73
46
398
@GileadSciences
Gilead Sciences
3 years
Hats off to our Gilead Mexico team for being recently recognized as a best place to work for the #LGBTQ community by the @HRC . We're proud!
Tweet media one
0
24
416
@GileadSciences
Gilead Sciences
5 years
Gilead announces the latest findings on an investigational long-acting agent for #HIV that was recently granted breakthrough therapy designation by the U.S. FDA. Read more about our progress: . #IAS2019
Tweet media one
11
92
388
@GileadSciences
Gilead Sciences
2 years
Jacquie was diagnosed with non-Hodgkin lymphoma when she was just 15 years old. Later in her life she received two breast cancer diagnoses. She explains why it's important to stay positive. #BreastCancerAwarenessMonth
0
79
363
@GileadSciences
Gilead Sciences
4 years
The way we see it, the impossible is not impossible. It’s simply what hasn’t been achieved yet. Come see what’s next: .
384
80
364
@GileadSciences
Gilead Sciences
3 years
Science is better when it’s inclusive and collaborative. This week at #HIVR4P , two of our virology experts led a discussion with global leaders about the importance of engaging the community early and regularly in #HIV prevention research.
Tweet media one
0
47
348
@GileadSciences
Gilead Sciences
4 years
Gilead continues to enable access to its investigational medication for COVID-19, supporting six clinical trials globally that are enrolling participants now.
24
100
349
@GileadSciences
Gilead Sciences
3 years
We’re focused on helping science while potentially developing prevention options for people who may benefit from PrEP medicines. At #IAS2021 , Gilead’s Chris Carter discusses our commitment to #HIV prevention research.
0
16
335
@GileadSciences
Gilead Sciences
3 years
Continued commitment to innovation and community collaboration are key components of #HIV research. In advance of #IAS2021 , hear from infectious disease physician Theo Hodge, who’s studying prevention strategies in communities most impacted by HIV.
Tweet media one
0
26
331
@GileadSciences
Gilead Sciences
2 years
Inspired by his local pharmacist while growing up, Jesse Garcia proudly works as a Senior Medical Scientist at Gilead. As Global Lead of the company’s Latino Employee Resource Group, he drives work centered around diversity, inclusion and access to care. #HispanicHeritageMonth
0
58
324
@GileadSciences
Gilead Sciences
2 years
This #EarthDay , we’re highlighting our longstanding commitment to environmental stewardship. We’ll continue to accelerate our efforts to reduce greenhouse gas emissions, minimize waste generation and operate responsibly. #InvestInOurPlanet
0
19
315
@GileadSciences
Gilead Sciences
4 years
Gilead statement on data from study in patients with severe COVID-19 in China: .
Tweet media one
65
200
324
@GileadSciences
Gilead Sciences
4 years
We have been working day and night, in collaboration with study investigators and governments, to determine whether our investigational drug might work in patients with COVID-19. Read more from our Chairman & CEO Daniel O’Day on today’s news: .
Tweet media one
33
94
312
@GileadSciences
Gilead Sciences
1 year
This week, Chairman and CEO Daniel O’Day had the opportunity to meet with stakeholders in Florida who are collaboratively expanding the FOCUS model in hospitals across the state. FOCUS is centered on best practices in #HIV , #HCV and #HBV screening, diagnosis and linkage to care.
Tweet media one
0
20
300
@GileadSciences
Gilead Sciences
4 years
Gilead is initiating two Phase 3 clinical studies to evaluate the safety & efficacy of an investigational compound for the treatment of COVID-19. The studies will enroll patients in Asia & other countries with a high number of confirmed COVID-19 cases.
Tweet media one
26
152
298
@GileadSciences
Gilead Sciences
4 years
Data on 53 patients treated with investigational antiviral for COVID-19 published in @NEJM : .
Tweet media one
22
160
288
@GileadSciences
Gilead Sciences
3 years
A world without long-term #HIV treatment will require collaboration and conversation across the entire community. We kicked off #IAS2021 by convening leading researchers, community collaborators and people living with HIV to discuss this important topic.
0
37
286
@GileadSciences
Gilead Sciences
4 years
An update from our Chairman & CEO Daniel O’Day on Gilead’s clinical trials for our investigational treatment for COVID-19: .
Tweet media one
41
116
290
@GileadSciences
Gilead Sciences
5 years
Watch Sir Elton John discuss our new RADIAN initiative, a joint effort with @ejaf that aims to address new HIV infections and deaths from AIDS-related illnesses in Eastern Europe and Central Asia. Learn more: . #FTC2019
0
50
295
@GileadSciences
Gilead Sciences
4 years
As #IDWeek2020 draws to a close, read the latest update from Merdad Parsey, Chief Medical Officer at Gilead, about our efforts to help address the COVID-19 pandemic.
55
51
285
@GileadSciences
Gilead Sciences
6 years
There is no cure for HIV, but prevention, testing and treatment can all work together to help us stop the virus. Learn more:
22
131
266
@GileadSciences
Gilead Sciences
4 years
#NationalComingOutDay began when #LGBTQ + activists united in the fight to end the #HIV epidemic. Today, we celebrate those pioneers as we continue working to help end HIV/AIDS once and for all.
Tweet media one
23
42
260
@GileadSciences
Gilead Sciences
4 years
Gilead signs non-exclusive voluntary licensing agreements with five generic manufacturers to further expand supply of our investigational antiviral for COVID-19 in 127 countries. Learn more about our efforts to increase supply globally: .
17
90
264
@GileadSciences
Gilead Sciences
3 years
Today more than half of new HIV diagnoses – and nearly half of related deaths – are in the Southern United States. With support from our COMPASS Initiative, local organizations are working to address the #HIVEpidemic in this region: #GileadCOMPASS
Tweet media one
0
49
259
@GileadSciences
Gilead Sciences
5 years
#CARTcell therapy is redefining how certain #bloodcancers are treated. Research is ongoing with the goal of treating a broader range of blood cancers. Learn more about how CAR T works:
4
75
240
@GileadSciences
Gilead Sciences
3 years
At #IDWeek2021 , we’re sharing innovative approaches to #HIV prevention clinical trial recruitment. Our goal is to enhance the participation of communities most impacted by the HIV epidemic, including Black and Latinx communities and transgender and gender non-binary individuals.
Tweet media one
0
18
238
@GileadSciences
Gilead Sciences
9 months
Our new site in Parsippany, N.J., is one of our largest non-manufacturing investments in the U.S. outside of our Foster City HQ. This continues our transformation strategy as we deliver innovative medicines to address life-threatening conditions and attract the brightest talent.
Tweet media one
0
37
245
@GileadSciences
Gilead Sciences
4 years
Statement from Gilead’s Chief Medical Officer Merdad Parsey: “Gilead is working closely with global health authorities to respond to the novel coronavirus (2019-nCoV) outbreak through the appropriate experimental use of our investigational compound."
82
81
244
@GileadSciences
Gilead Sciences
3 years
Ending the #HIVEpidemic requires eliminating barriers and expanding access to healthcare services. Gilead is proud to support COMPASS grantees like the Transinclusive Group, which is fighting to end HIV-related stigma and change perceptions in southern Florida. #GileadCOMPASS
Tweet media one
0
17
236
@GileadSciences
Gilead Sciences
3 years
Today, we celebrate all women who have made contributions in medicine and science. Among them: Laura Bauer, a scientist who helped advance Gilead’s investigational antiviral in the early days of COVID-19. #WomeninScience
0
31
236
@GileadSciences
Gilead Sciences
3 years
We're matching up to $1 million for @BCEFA ’s #RedBucketMatchUp , which supports #HIV programs impacted by the pandemic. We aim to help organizations provide services to people living w/ or at risk for HIV:
Tweet media one
0
18
212
@GileadSciences
Gilead Sciences
4 years
Our manufacturing teams are working to scale up production of our investigational COVID-19 treatment. Read more: .
Tweet media one
14
84
227
@GileadSciences
Gilead Sciences
7 years
Our #WeekofService volunteers supporting @WeAreFredFinch today! #Gilead30
Tweet media one
9
12
220
@GileadSciences
Gilead Sciences
4 years
This National Latinx AIDS Awareness Day, meet Bamby Salcedo, founder of @TransLatina_C and an advocate for #HIV awareness and prevention. #NLAAD
13
31
186
@GileadSciences
Gilead Sciences
3 years
Through our COMPASS Initiative, we support local leaders & organizations helping people living with #HIV . Tarik Daniels, Whatsinthemirror? founder, provides arts-based programming to address social justice issues, HIV & mental health-related stigma:
Tweet media one
0
18
193
@GileadSciences
Gilead Sciences
2 years
#AIDS2022 kicks off next week, and we’re eagerly awaiting the opportunity to collaborate, learn and connect in person again as we work together to help end the #HIV epidemic for everyone, everywhere.
0
34
194
@GileadSciences
Gilead Sciences
7 years
For 30 years we have worked to address the unmet medical needs of patients with life-threatening illnesses around the world. #Gilead30
6
31
182
@GileadSciences
Gilead Sciences
4 years
The @US_FDA today approved our antiviral to treat patients with COVID-19 requiring hospitalization. Read more: .
Tweet media one
23
82
191
@GileadSciences
Gilead Sciences
4 years
@FYang_EP @FYang_EP , thank you for reaching out. Please check your DMs for info on how to reach the appropriate Gilead contact. We are working around the clock to initiate clinical trials of remdesivir to help address the urgent need for treatment. For more info: .
6
27
185
@GileadSciences
Gilead Sciences
3 years
Ending the HIV epidemic takes collective action and advocacy. We are proud to partner with organizations like @aids_memorial that are offering support during the COVID-19 pandemic.
12
14
180
@GileadSciences
Gilead Sciences
2 years
We’re happy to share the great work being done at Sustained Health Initiatives of the Philippines to help end the #HIV epidemic. See the full story at #TogetherAgainstHIV
0
38
178
@GileadSciences
Gilead Sciences
3 years
Gilead is proud to recognize our partner organizations this #WorldAIDSDay as we work together to help end the HIV epidemic.
28
19
178
@GileadSciences
Gilead Sciences
9 months
Gilead has been at the forefront of helping transform the treatment and prevention of #HIV for decades. Here, Kathryn Kersey, Executive Director, Virology Clinical Development looks at the innovative work being done to develop therapies for children.
0
15
187
@GileadSciences
Gilead Sciences
7 years
Gilead employees in Foster City, CA honor #WorldAIDSDay
Tweet media one
2
70
181
@GileadSciences
Gilead Sciences
6 years
Do your part to promote #HIV prevention. Find testing sites near you with this interactive @AIDSVu locator: . #WorldAIDSDay
Tweet media one
8
83
174
@GileadSciences
Gilead Sciences
6 years
In recognition of #WorldAIDSDay , use our filter on @SnapChat and share on: .
Tweet media one
7
41
166
@GileadSciences
Gilead Sciences
9 months
In the latest video in the “5 Years, 5 Voices” series, @BeOurCOMPASS grantee, the Vision Community Foundation in Atlanta, is building a bridge between the faith community and Pride.
0
12
168
@GileadSciences
Gilead Sciences
4 years
Ending the HIV/AIDS epidemic requires collaboration between different geographies, industries, organizations and individuals. We want to say thank you to everyone at #HIVGlasgow who is working to help end the HIV/AIDS epidemic.
11
22
162
@GileadSciences
Gilead Sciences
5 years
For over 30 years, we’ve never wavered in our commitment to innovation in #HIV . Our latest findings from our HIV cure research program were presented today at #IAS2019 . Learn more: .
Tweet media one
5
27
162
@GileadSciences
Gilead Sciences
2 years
Gilead is proud to support #ViralHepatitis Elimination 2022. We’re joining the hepatitis community to discuss how to help overcome the remaining barriers and challenges to achieve the goal of viral hepatitis elimination by 2030. #EASLspecial
Tweet media one
0
20
152
@GileadSciences
Gilead Sciences
4 years
Gilead stands in solidarity and empathy with our Black employees, their families and African American communities everywhere and we condemn racism of any kind.
10
26
160
@GileadSciences
Gilead Sciences
2 years
Our #HIV treatment research program is focused on helping people with HIV continue achieving long-term treatment success. The data at #AIDS2022 can help provide additional insights into redefining HIV treatment success beyond viral load suppression.
0
37
156
@GileadSciences
Gilead Sciences
2 years
Hepatitis delta can have a devastating impact on those it affects and can lead to more rapid progression of liver-related death than hepatitis B alone. At Gilead, we continue to strive to help address the unmet needs of people living with #HDV .
0
29
148
@GileadSciences
Gilead Sciences
7 years
Attending #ACR16 ? Visit Gilead at Booth 2122 to learn more about our clinical trials in #RheumatoidArthritis
Tweet media one
5
38
150
@GileadSciences
Gilead Sciences
9 months
Stacey Ma, Executive Vice President of Pharmaceutical Development and Manufacturing, oversees a team that’s deeply involved in every stage of the process of creating a new medicine. She shares here what it takes to deliver transformative therapies as quickly as possible.
0
18
155
@GileadSciences
Gilead Sciences
3 years
This #WorldAIDSDay , Gilead is committed to supporting the global HIV community, working together to help end the epidemic.
11
17
151
@GileadSciences
Gilead Sciences
3 years
At Gilead, we’re committed to responsible growth – and we’re honored to receive a 2021 Facility of the Year Award from @ISPEorg . See how we’re building collaborative, environmentally sustainable and operationally agile workspaces that inspire innovation:
0
16
140
@GileadSciences
Gilead Sciences
4 years
Gilead is working to further accelerate and maximize global supply of our investigational antiviral for COVID-19. Read more about our plans, including generic licensing and partnerships with leaders in global health: .
17
60
148
@GileadSciences
Gilead Sciences
4 years
Gilead announces results from Phase 3 trial of our investigational antiviral drug in patients with moderate COVID-19: .
Tweet media one
11
60
148
@GileadSciences
Gilead Sciences
4 years
At Gilead we care. During these challenging times, if you have lost your job and no longer have insurance coverage for your Gilead medicines, we are here to help.
12
46
143
@GileadSciences
Gilead Sciences
4 years
Gilead adds four additional generic manufacturers in Egypt and India to our non-exclusive voluntary licensing agreements to further expand supply of our investigational antiviral for COVID-19 in 127 countries. Learn more here: .
8
80
146
@GileadSciences
Gilead Sciences
4 years
Due to overwhelming demand, we are in the process of transitioning our compassionate access program to expanded access programs as rapidly as possible. Read more: .
27
49
144